Wealth Trust Axiom LLC Biogen Inc. Transaction History

Wealth Trust Axiom LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$194.69 - $268.46 $168,601 - $232,486	866 New	866 $231,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $167,804 - $211,425	-866 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$282.99 - $369.05 $1,697 - $2,214	6 Added 0.7%	866 $245,000
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $13,002 - $20,337	-60 Reduced 6.52%	860 $203,000
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $258,657 - $303,314	920	920 $288,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Trust Axiom LLC with notifications on news.